Furthermore, the inhibition or knockdown of ABCG2 in rodent models can enhance the accumulation of chemotherapeutic drugs in the brain, suggesting a potential strategy to improve drug delivery and efficacy in glioma treatment [22]. The gene discussed is ABCG2; the disease is glioma.